| CONTACT: Richard R. Current,
Vice President & CFO ,
517/372-9200 |
Neogen again one of Fortune’s
fastest-growing small companies
LANSING, Mich., July 2, 2003 —
For the second consecutive year, Neogen Corporation (Nasdaq: NEOG)
has been named to Fortune Small Business’ list of the 100
fastest-growing, publicly-held small businesses in America.
Companies were ranked based on three
criteria: earnings growth, revenue growth and stock performance
over the past three years. The three criteria were then averaged
to create the final list. For the period of March 1, 2000 to Feb.
28, 2003, Neogen had an average annual revenue growth rate of 19%,
average annual increase in net income of 24%, and average annual
increase in its stock price of 19%. Neogen’s growth in operating
income during the same three-year period averaged 35%.
Neogen
is scheduled to release the results of its 2003 fiscal year, which
ended May 31, on July 22.
“We
are very pleased that this respected financial publication has once
again recognized our company’s financial performance as one
of the best in America,” said James Herbert, Neogen’s
president. “In the financial community, as well as in our
food and animal safety industry, trust is earned. We’re extremely
proud of the trust we’ve earned from our customers and investors
to make this recognition possible.”
Compiled
with help from Zacks Investment Research, the Fortune Small Business
100 list took into consideration only companies traded on major
exchanges with $200 million or less annual revenue, and with a stock
price above $1. The complete list appears in the July/August issue
of Fortune Small Business.
Neogen
Corporation develops and markets products and services dedicated
to food and animal safety. The Company’s Food Safety Division
markets dehydrated culture media, and diagnostic test kits to detect
foodborne bacteria, natural toxins, genetic modifications, food
allergens, drug residues, plant diseases and sanitation concerns.
Neogen’s Animal Safety Division markets a complete line of
diagnostics, veterinary instruments, veterinary pharmaceuticals
and nutritional supplements.
Certain portions of this news release that do not relate to historical
financial information
constitute forward-looking statements. These forward-looking statements
are subject to
certain risks and uncertainties. Actual future results and trends
may differ materially from
historical results or those expected depending on a variety of factors
listed in
Management’s Discussion and Analysis of Financial Condition
and Results of
Operations in the Company’s most recently filed Form 10-K.
|